Organs-on-chips or OOCs are special types of small plastic devices with biocompatible microfluidic chambers that include various live human cells in the 3D culture that simulate fundamental physiological functions of body organs. These cells are generally placed in an environment that artificially mimics of human body aspects for instance movement, electrical stimuli, flow, morphology, and liquid gradients. It is anticipated that increasing health problems and rising demand for lung & kidney based organ culture devices will have a significant impact on the organ-on-chip market throughout the forecast period. Moreover, increase in initiatives by leading organizations to implement the organ-on-chips technology is suggested to fuel the growth of organ-on-chip market.
As per analysis, Europe Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity. Some of the major companies that are currently functioning in the Europe organ-on-chip market include TissUse GmbH, MIMETAS BV, Cherry Biotech, Hurel Corporation, Nortis Inc., BiomimX SRL, Tara Biosystems Inc., InSphero AG, Emulate Inc., Organovo, Inc., CN Bio Innovations, Ltd., Cherry Biotech, SynVivo, Inc. and among others.
In terms of organ type, Europe organ-on-chip market is bifurcated into lung-on-a-chip, vessels-on-a-chip, heart-on-a-chip, liver-on-a-chip, skin-on-a-chip, kidney-on-a-chip, brain-on-a-chip and others. In terms of offering, market is bifurcated as chips and services. In terms of material type, market is bifurcated as silicon, glass and polymers. In terms of application types, market is bifurcated as drug discovery and toxicology research. Additionally, in terms of end-user, market is bifurcated into cosmetic industry, academic & research institutes and pharmaceutical & biotechnology companies.
The increasing use of drugs, expanding pharmaceutical companies & organ-on-a-chip manufacturers, and growing need for early detection of drugs are key factors promoting the organ-on-chip market growth in the European region. This organ-on-chips helps to understand the micro-environment by body’s cells of various functions including mechanical forces, chemical interactions, and biological effects. Organ-on-chip offers many advantages for the development of targeted therapies over traditional techniques. This helps to develop disease modalities and precisely predict the effectiveness & toxicity of drugs; these properties should stimulate the growth of the European market for organ-on-chips. In addition, research on organ-on-chips provides an opportunity to improve the testing of new drugs or therapies to predict their safety in cardiovascular disease, drug abuse, cancer, etc., as well as their effectiveness in the human body. These micro-fabricated living systems can also reduce reliance on animal testing, thereby lowering production costs, reducing clinical trial time, and improving antibody resistance.
By geographic analysis, the Europe organ-on-chip market is bifurcated into UK, France, Italy, Germany, Spain, Russia and rest of the Europe. UK country is likely to hold major share in regional market owing to high prevalence of cardiovascular diseases, rise in availability of new & advanced organ-on-a-chip models, presence of key pharmaceutical companies and favorable government initiatives. Moreover, Germany country accounted for second-major share in the European market due to extensive development & research, increase in funding and high healthcare expenses over the forecast period. It is predicted that the Europe organ-on-chip market will be reached at rapid pace because of increase in use of OOC in early detection of drug toxicity, emergence of OOC as an alternative to animal testing, rise in demand for personalized medicine and significant increase in research funding & venture capital investments during the forecast period.
For More Information, click on the link below:-
Europe Organ-on-Chip Market Research Report
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249